Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 2
2,360
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Progenies of gestational diabetes mellitus exhibit sex disparity in metabolism after respective therapies of insulin, glibenclamide, and metformin in dams during pregnancy

, , , , , & show all
Pages 183-195 | Received 27 Jun 2021, Accepted 06 Oct 2021, Published online: 23 Oct 2021

References

  • American Diabetes Association. 2013. Diagnosis and classification of diabetes mellitus. Diabetes care, 36 (1), S67–S74.
  • Boese, A.C., et al., 2017. Sex Differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. American journal of physiology heart and circulatory physiology, 313 (3), H524–H545.
  • Crowther, C.A., et al., 2005. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England journal of medicine, 352 (24), 2477–2486.
  • Danaei, G., et al., 2011. National, regional, and global trends in fasting plasma and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 378 (9785), 31–40.
  • Díaz-Delfín, J., Morales, M., and Caelles, C., 2007. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. Diabetes, 56 (7), 1865–1871.
  • George, A., et al., 2015. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide-a randomised controlled trial. The Australian & New Zealand journal of obstetrics & gynaecology, 55 (1), 47–52.
  • Han, T., et al., 2019. PPARγ overexpression regulates cholesterol metabolism in human L02 hepatocytes. Journal of pharmacological sciences, 139 (1), 1–8.
  • Hanson, R.L., et al., 2002. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes, 51 (10), 3120–3127.
  • Hernández-Rodas, M.C., et al., 2017. Supplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR-α and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation. Molecular nutrition & food research, 61 (12), 1–35.
  • Hevener, A.L., et al., 2007. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. The journal of clinical investigation, 117 (6), 1658–1669.
  • Hod, M., et al., 2015. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. International journal of gynaecology and obstetrics: the official organ of the international federation of gynaecology and obstetrics, 131 (3), S173–S211.
  • Howard, B.V., et al., 2013. The women’s health initiative hormone therapy trials: update and overview of health outcomes during the intervention and post-stopping phases. JAMA, 310 (13), 1353.
  • Ijas, H., et al., 2015. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG, 122 (7), 994–1000.
  • Kelly, D.M., et al., 2016. Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse. Endocrine, 54 (2), 504–515.
  • Kim, C., et al., 2013. Reductions in glucose among postmenopausal women who use and do not use estrogen therapy. Menopause, 20 (4), 393–400.
  • Klopotek, A., Hirche, F., and Eder, K., 2006. PPARγ ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Experimental biology and medicine, 231 (8), 1365–1372.
  • Krishnaveni, G.V., et al., 2010. Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes care, 33 (2), 402–404.
  • Langer, O., 2002. Oral hypoglycemic agents in pregnancy: their time has come. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of perinatal medicine, the federation of Asia and Oceania perinatal societies, the international society of perinatal obstetricians, 12 (6), 376–383.
  • Lebovitz, H.E., 1999. Type 2 diabetes: an overview. Clinical chemistry, 45 (8), 1339–1345.
  • Lee, J.H., et al., 2017. PPARα-dependent Insig2a overexpression inhibits SREBP-1c processing during fasting. Scientific reports, 7 (1), 9958.
  • Lee, O.D. and Tillman, K., 2016. An overview of testosterone therapy. American journal of men’s health, 10 (1), 68–72.
  • Lightfoot, J.T., 2008. Sex hormones’ regulation of rodent physical activity: a review. International journal of biological sciences, 4 (3), 126–132.
  • Louet, J.F., LeMay, C., and Mauvais-Jarvis, F., 2004. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Current atherosclerosis reports, 6 (3), 180–185.
  • Maseroli, E., et al., 2016. PS-01-008 Testosterone supplementation and bodycomposition: results from a meta-analysis study. The journal of sexual medicine, 13 (5), S78.
  • McIlvride, S., et al., 2019. Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. American journal of physiology-endocrinology and metabolism, 317 (2), E399– E410.
  • Minnich, A., et al., 2001. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. American journal of physiology endocrinology and metabolism, 280 (2), E270–E27 9.
  • Misso, M.L., et al., 2003. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology, 144 (4), 1474–1480.
  • Moretti, C., et al., 2017. Androgens and hypertension in men and women: a unifying view. Current hypertension reports, 19 (5), 44.
  • Murakami, T., et al., 1997. Enlargement of glycogen store in rat liver and muscle, by fructose-diet intake and exercise training. Journal of applied physiology, 82 (3), 772–775.
  • Nachum, Z., et al., 2017. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes care, 40 (3), 332–337.
  • Nanobashvili, K., et al., 2018. Maternal choline and betaine supplementation modifies the placental response to hyperglycemia in mice and human trophoblasts. Nutrients, 10 (10), 1507.
  • Odegaard, J.I., et al., 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature, 447 (7148), 1116–1120.
  • Portha, B., Chavey, A., and Movassat, J., 2011. Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass. Experimental diabetes research, 2011, 105076.
  • Ren, J., et al., 2018. Intrauterine hyperglycemia exposure results in intergenerational inheritance via DNA methylation reprogramming on F1 PGCs. Epigenetics & chromatin, 11 (1), 20.
  • Ren, T., et al., 2017. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Nutrients, 9 (3), 198.
  • Salpeter, S.R., et al., 2006. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, obesity & metabolism, 8 (5), 538–554.
  • Shuster, D.L., et al., 2014. Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age. Journal of pharmacology and experimental therapeutics, 350 (2), 425–434.
  • Webber, J., Charlton, M., and Johns, N., 2015. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. British journal of diabetes, 15 (3), 107.
  • Xiao, D., et al., 2017. Prenatal food restriction with postweaning high-fat diet alters glucose metabolic function in adult rat offspring. Archives of medical research, 48 (1), 35–45.
  • Yan, H., et al., 2019. Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes, 68 (2), 291–304.
  • Yuchi, Y., et al., 2015. Estrogen receptor α regulates β-cell formation during pancreas development and following injury. Diabetes, 64 (9), 3218–3228.